Fed's Kaplan: Resurgence of virus is muting economic recovery, more aid needed

NEW YORK (Reuters) - The resurgence of coronavirus infections has muted the economic recovery and Congress needs to support the economy by continuing to provide enhanced unemployment benefits and aid to state and local governments, Dallas Federal Reserve Bank President Robert Kaplan said on Wednesday. 'I believe the economy needs a continuation of the unemployment benefits,' Kaplan said during an interview with CNN. 'It may not need to be in the same form as it currently is, but we need a continuation.' Kaplan declined to say exactly how much aid he thinks lawmakers should provide, but he said the support, along with widespread use of masks, is critical to helping the economy recover

Reuters August 06, 2020 00:06:55 IST
Fed's Kaplan: Resurgence of virus is muting economic recovery, more aid needed

Feds Kaplan Resurgence of virus is muting economic recovery more aid needed

NEW YORK (Reuters) - The resurgence of coronavirus infections has muted the economic recovery and Congress needs to support the economy by continuing to provide enhanced unemployment benefits and aid to state and local governments, Dallas Federal Reserve Bank President Robert Kaplan said on Wednesday.

"I believe the economy needs a continuation of the unemployment benefits," Kaplan said during an interview with CNN. "It may not need to be in the same form as it currently is, but we need a continuation."

Kaplan declined to say exactly how much aid he thinks lawmakers should provide, but he said the support, along with widespread use of masks, is critical to helping the economy recover.

He projected that U.S. GDP will grow at an annualized rate of 20% in the third quarter, but still expects the U.S. economy to contract by about 5% for the year.

The Fed official said the pace of the recovery will depend on the virus. Kaplan said further shutdowns may be needed in some parts of the country if it appears healthcare systems are at risk of becoming overwhelmed, and emphasized that widespread use of masks can help bring infections down to a more manageable level.

"The issue with the resurgence in the virus is it slowed down or somewhat muted the recovery we’ve been expecting," Kaplan said. "So the better again we manage the virus, the better we’ll recover."

(Reporting by Jonnelle Marte in New York; Editing by Franklin Paul and Matthew Lewis)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

China bans German pork imports after African swine fever case
Business

China bans German pork imports after African swine fever case

SHANGHAI (Reuters) - China banned pork imports from Germany on Saturday after it confirmed its first case of African swine fever last week, in a move set to hit German producers and push up global prices as China's meat supplies tighten. China's ban on imports from its third largest supplier comes as the world's top meat buyer deals with an unprecedented pork shortage after its own epidemic of the deadly hog disease. The ban on Germany, which has supplied about 14% of China's pork imports so far this year, will push up demand for meat from other major suppliers like the United States and Spain, boosting global prices.

Libya's Haftar committed to ending oil blockade, U.S. says
Business

Libya's Haftar committed to ending oil blockade, U.S. says

CAIRO (Reuters) - Libyan commander Khalifa Haftar has committed to ending a months-long blockade of oil facilities, the U.S.

AstraZeneca resumes UK trials of COVID-19 vaccine halted by patient illness
Business

AstraZeneca resumes UK trials of COVID-19 vaccine halted by patient illness

By Michael Holden LONDON (Reuters) - AstraZeneca has resumed British clinical trials of its COVID-19 vaccine, one of the most advanced in development, after getting the green light from safety watchdogs, the company said on Saturday. The late-stage trials of the experimental vaccine, developed with researchers from the University of Oxford, were suspended this week after an illness in a study subject in Britain, casting doubts on an early rollout